Fondazione per la Ricerca Ospedale di Bergamo

Fondazione per la Ricerca Ospedale di Bergamo (FROM) is an independent non-profit research foundation based in Italy that conducts and supports clinical research at the ASST Papa Giovanni XXIII hospital. Founded in 2008, the foundation specializes in the management of clinical trials, particularly in the fields of hematology, oncology, and cardiovascular medicine. FROM is internationally recognized for its leadership in research on myeloproliferative neoplasms (MPN) and provides a range of services including regulatory support, data management, and biobanking. The organization acts as a strategic partner for both academic institutions and the pharmaceutical industry to translate scientific discoveries into improved clinical outcomes. It operates a Phase I Clinical Trial Unit, enabling the testing of innovative therapies in early development stages. Through its extensive network, FROM coordinates multi-center international studies that contribute significantly to global clinical guidelines.